Tomoo Ikari

Assistant professor

Tohoku University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Tomoo Ikari is an Assistant Professor at Tohoku University in Japan. His research focuses on palliative care, particularly involving the management of dyspnea in cancer patients. Recent articles include studies on the effectiveness of pharmacological treatment algorithms and the use of opioids for terminal dyspnea. He is also involved in exploring predictive factors for prognosis in advanced cancer patients.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (1)

Takashi Yamaguchi

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tomoo Ikari

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

The feasibility and effects of a pharmacological treatment algorithm for cancer patients with terminal dyspnea: A multicenter cohort study

Systemic Opioids for Dyspnea in Cancer Patients: A Real-world Observational Study

Effectiveness and safety of opioids for dyspnea in patients with lung cancer: secondary analysis of multicenter prospective observational study

Factors associated with good death of patients with advanced cancer: a prospective study in Japan.

Case Report: Hereditary Fibrosing Poikiloderma With Tendon Contractures, Myopathy, and Pulmonary Fibrosis (POIKTMP) Presenting With Liver Cirrhosis and Steroid-Responsive Interstitial Pneumonia.

Morphine May Contribute to Improving Respiratory Failure in Severe COVID-19: A Case Report.

Is the 1-day surprise question a useful screening tool for predicting prognosis in patients with advanced cancer?-a multicenter prospective observational study.

Predictive Factors for the Development of Dyspnea Within 7 Days After Admission Among Terminally Ill Cancer Patients.

The Possibility of Conducting a Clinical Trial on Palliative Care: A Survey of Whether a Clinical Study on Cancer Dyspnea Is Acceptable to Cancer Patients and Their Relatives.

"3-Day Surprise Question" to predict prognosis of advanced cancer patients with impending death: Multicenter prospective observational study.

Collaborators (1)

Takashi Yamaguchi

Make your next move.